2-Apr-2026
Prenetics Brings Giannis Antetokounmpo Onboard as IM8 Global Partner and Shareholder
TipRanks (Thu, 2-Apr 9:56 AM ET)
Globe Newswire (Thu, 2-Apr 9:00 AM ET)
Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation
Globe Newswire (Tue, 24-Mar 11:00 AM ET)
Prenetics to Participate in the 38th Annual ROTH Conference
Globe Newswire (Wed, 18-Mar 8:30 AM ET)
Prenetics Authorizes $40 Million Share Repurchase Program
Globe Newswire (Fri, 6-Mar 8:00 AM ET)
Globe Newswire (Tue, 3-Mar 8:00 AM ET)
Prenetics Launches IM8 Daily Ultimate Essentials PRO - A Clinical Formula with Two New Flavours
Globe Newswire (Mon, 23-Feb 9:00 AM ET)
Globe Newswire (Wed, 18-Feb 9:11 AM ET)
Globe Newswire (Tue, 17-Feb 4:30 PM ET)
Globe Newswire (Tue, 17-Feb 8:00 AM ET)
Prenetics Global Ltd is a health sciences company dedicated to advancing consumer health. The consumer initiative is led by IM8, one of the world's fastest-growing supplement brands; Europa, one of the sports distribution companies in the USA; and CircleDNA, a direct-to-consumer DNA testing company. As the first consumer healthcare company to establish a Bitcoin treasury with its initial approximately $20 million Bitcoin purchase and board-approved comprehensive Bitcoin plan of action, Prenetics is pioneering the intersection of healthcare innovation and digital asset adoption.
Prenetics Global Limited - Class A Ordinary Share trades on the NASDAQ stock market under the symbol PRE.
As of April 2, 2026, PRE stock price climbed to $19.68 with 111,907 million shares trading.
PRE has a beta of 0.22, meaning it tends to be less sensitive to market movements. PRE has a correlation of 0.00 to the broad based SPY ETF.
PRE has a market cap of $331.18 million. This is considered a Small Cap stock.
In the last 3 years, PRE traded as high as $23.63 and as low as $2.85.
The top ETF exchange traded funds that PRE belongs to (by Net Assets): IWC, BCOR.
PRE has outperformed the market in the last year with a return of +398.2%, while the SPY ETF gained +18.2%. In the last 3 month period, PRE beat the market returning +25.0%, while SPY returned -3.6%. However, in the most recent 2 weeks PRE has underperformed the stock market by returning -3.8%, while SPY returned -0.6%.
PRE support price is $18.28 and resistance is $20.86 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRE shares will trade within this expected range on the day.